Advisors

AcuityBio has assembled a world class advisory team of industry experts.


Benedict Daly, MD. Dr. Daly is the Clinical Director of General Thoracic Surgery at the Boston University School of Medicine. He is a board certified Thoracic Surgeon and specializes in Tumors of the Lung, Esophagus, Mediastinum, Chest Wall and Diaphragm; Benign Disorders of the Esophagusincluding Gastroesophageal Reflux Disease; Thoracoscopic Surgery; Laser Bronchoscopy, tracheobronchial Stents, and Bracchytherapy.


Alain Hanover. Mr. Hanover is co-founder of AcuityBio and is a successful serial entrepreneur, having raised millions for his and other companies. He has participated as CEO, Chairman, or Venture Capital investor in five Life Sciences companies.


Philip Linden, MD. Dr. Linden is the Chief of the Division of Thoracic Surgery at Case Western Medical Center/University Hospitals. He is a board certified Thoracic Surgeon and specializes in Minimally Invasive (VATS) Lung and Esophageal Surgery, Thoracic Oncology, High Risk Chest Surgery, and Lung Cancer In the Emphysema Patient.


Michael Rabin, MD. Dr. Rabin is the Clinical Director of the Lowe Center for Thoracic Oncology at the Dana Farber Cancer Institute, and Assistant Professor of Medicine at the Harvard Medical School, Brigham and Women's Hospital. He is a clinical oncologist specializing in lung cancer and mesothelioma.


Steven Schwaitzberg, MD. Dr. Schwaitzberg is the Chief of Surgery at the Cambridge Health Alliance, an advisor to the FDA, and President-elect of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). He is a Gastrointestinal and Endocrine Surgeon specializing Laparoscopic Cholecystectomy/Bile Duct Exploration, Laparoscopic Colon Resection, Laparoscopic Distal Pancreatectomy/Splenectomy, Laparoscopic Adrenalectomy, Laparoscopic Gastrointestinal Procedures, Thyroid Lobectomy, Thyroidectomy, Lymph Node Biopsy, and clinical trials.


Arthur Rosenthal, Ph.D. Dr. Rosenthal is the Executive Vice-Chairman of Cappella, Inc, Cofounder and Chairman of LabCoat, Inc, and former CSO of Boston Scientific. He specializes in medical device companies, technical development, and drug-eluting stents.


Eyal Ron, Ph.D. Dr. Ron has over 20 years of experience in the development of drugs, biomaterials and drug delivery systems. He developed and commercialized Gliadel®, InFuse®, ProLease®.